Connect with us


Johnson & Johnson vaccine hits production snags – POLITICO

The company could seek emergency authorization from FDA this month, but supplies may be thin at first.



post featured image

A Johnson & Johnson spokesperson declined to confirm the delay, but said the company remains “confident in our ability to meet our 2021 supply commitments.”
“We remain in active discussions with regulators, including on the approval and validation of our manufacturing processes,” the spokesperson said.
“Operation Warp Speed is working with Johnson & Johnson to scale up and maximize manufacturing of the Janssen vaccine,” an HHS spokesperson said. “Making projections at this time is premature.”

Click here to view the original article.

Continue Reading

You might also like ...

post featured image
Why Netflix stock is going haywire after its latest earnings report – Yahoo Finance
post featured image
P&G raises forecast after earnings top expectations, fueled by 8% jump in sales – CNBC
post featured image
Morgan Stanley beats estimates on better-than-expected Wall Street and wealth management results – CNBC